|Bid||0.370 x 0|
|Ask||0.375 x 0|
|Day's Range||0.355 - 0.560|
|52 Week Range||0.070 - 0.760|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
On the heels of Canada’s recreational cannabis legalization, the time has come at last for those companies flying under the radar that have quietly been preparing for this very moment. BlissCo (CSE:BLIS) is one of those players, meticulously readying its facility and building its international ecosystem. BlissCo earned its ACMPR license in March 2018 and began trading on the Canadian Securities Exchange.
BlissCo Cannabis Corp. (CSE:BLIS) (FRA:GQ4B), (“BlissCo”) is pleased to announce that it has made its first footprint in Europe by signing a non-binding Letter of Intent (“LOI”) to sell 720 kilos of dried cannabis flower to a German biomedical and distribution company (“the Importer”). “Our German partner will promote the responsible use of cannabis for medicinal purposes, providing international expansion to the distribution arm of the BlissCo ecosystem,” said Damian Kettlewell, BlissCo CEO. With federal health insurance coverage for medical cannabis and population of nearly 82 million, Germany has become one of the largest legal medical cannabis markets in the world.
VANCOUVER, British Columbia, June 20, 2018 (GLOBE NEWSWIRE) -- BlissCo Cannabis Corp. (CSE:BLIS) (FRA:GQ4B), (“BlissCo”) is pleased to announce that Dr. Bryn Hyndman, former medical director of Qi Integrated Health, is joining BlissCo’s advisory board. Dr. Hyndman is a board-certified medical doctor with the Canadian College of Family Physicians (CCFP) and a naturopath. “We are focused on building a strong ecosystem that includes partners such as Dr. Hyndman to enable us to establish the BlissCo brand as a premium craft cannabis product in the medical market and recreational market when it is legal,” said Damian Kettlewell, CEO of BlissCo Cannabis Corp.
VANCOUVER, June 13, 2018 /CNW/ - BlissCo Cannabis Corp. (CSE:BLIS.CN - News) (FRA:GQ4B.F - News), ("BlissCo") submitted a license amendment application to Health Canada to produce cannabis oil on June 6, 2018.
CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article covering the strategy and positioning of BlissCo Cannabis Corp. (BLIS.CN) (BLIS.CN) (BLIS.CN), a licensed producer that recently went public in Canada. Partnerships, licenses, management, and location are among these differentiating factors, and BlissCo is one of the young producers with a strong resume in all of these areas. With adult-use legalization on the horizon and the legal cannabis market set to explode, BlissCo looks ready to carve out its niche in the multi-billion dollar industry.
VANCOUVER, May 31, 2018 /CNW/ - BlissCo Cannabis Corp. (FRA:GQ4B.F - News) (CSE:BLIS.CN - News), ("BlissCo") is pleased to announce that the company is now listed on the Frankfurt Stock Exchange and is trading under the symbol GQ4B. 35% of the world's investment capital is represented on the Frankfurt Stock Exchange. This new listing will provide BlissCo with broader access to international investors in Europe and beyond.
VANCOUVER, May 23, 2018 /CNW/ - BlissCo Cannabis Corp. (CSE:BLIS.CN - News) is pleased to provide a corporate update on the company's wholly-owned subsidiary, Bliss Co Holdings Ltd. ("BlissCo"). "We are seeing tremendous momentum and interest as we continue to expand our team and put all the pieces into place for a successful product launch once our sales license is approved." said Damian Kettlewell, CEO of Blissco Cannabis Corp.
VANCOUVER, May 8, 2018 /CNW/ - BlissCo Cannabis Corp. (CSE:BLIS.CN - News) is pleased to announce that the company's wholly-owned subsidiary, Bliss Co Holdings Ltd. ("BlissCo"), has received its order of cuttings at its facility in Langley. BlissCo received the cuttings on May 2, 2018, from 7ACRES which is a Licensed Producer and wholly owned subsidiary of The Supreme Cannabis Company, Inc. (TSX.V:FIRE.V - News). This will enable the team to start the process to earn our sales license in an expedient manner." said Damian Kettlewell, BlissCo CEO.
VANCOUVER, April 12, 2018 /CNW/ - BlissCo Cannabis Corp. (CSE:BLIS.CN - News) ("Company") is pleased to announce that the Company's wholly-owned subsidiary, Bliss Co Holdings Ltd. ("BlissCo") earned its Occupancy Permit from the Township of Langley on April 6, 2018. "Earning our Occupancy Permit from the Township of Langley is a significant municipal milestone following up on BlissCo's ACMPR License to Cultivate that Health Canada granted us on March 29, 2018.
VANCOUVER, April 2, 2018 /CNW/ - BlissCo Cannabis Corp. (CSE:BLIS.CN - News) ("BlissCo" or the "Company") is pleased to announce that the Company's wholly-owned subsidiary, Bliss Co Holdings Ltd. ("BlissCo") has been granted a licence by Health Canada to cultivate cannabis plants and prepare dried cannabis. "Our ACMPR licence to cultivate allows us to execute on our strategic plan to build a distribution, brand and extraction focused cannabis company.